PapersPMID:27763802
A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms.
What moved
1 findingHow to read these marks →- Decreases Kupperman Menopausal Index total score
very limited
“Total KI scores were significantly lower in the BMO-30 group than in the placebo group when evaluated with respect to group and time (p = 0.042).”
- Study
- RCT
- Dose studied
- treatment for 6 weeks, followed for 12 weeks; dose not stated in the abstract
- Population
- Women aged 40 to 70 years complaining of menopausal symptoms on the Kupperman Index; 41 eligible, 36 completed (18 per group); group-by-time analysis over the 12-week follow-up
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Women between the ages of 40 and 70 years complaining of menopausal symptoms measured by the Kupperman Index
- Participants
- 36
- Comparator
- placebo
- Duration
- 42 days
- Endpoints measured
- 4